Patient info Search Menu

Mycophenolate Mofetil Tillomed 250 mg capsules – patient leaflet, side effects, dosage

Updated:
Key facts
Status:
Prescription only (POM)
Medicine strength:
250 mg
Contains active substance:

Patient leaflet - Mycophenolate Mofetil Tillomed 250 mg capsules

What Mycophenolate mofetil is and what it is used for

Mycophenolate mofetil 250 mg capsules contains mycophenolate mofetil. This belongs to a group of medicines called “immunosuppressants”. Mycophenolate mofetil is used to prevent your body from rejecting a transplanted kidney, heart or liver. Mycophenolate mofetil should be used together with other medicines such as ciclosporins and corticosteroids.

2

What you need to know before you take Mycophenolate mofetil

WARNING

Mycophenolate mofetil with food and drink

Taking food and drink has no effect on your treatment with Mycophenolate mofetil.

Pregnancy, contraception and breast-feeding

Contraception in women taking

Mycophenolate mofetil

If you are a woman who could become pregnant you must use an effective method of contraception with Mycophenolate mofetil. This includes:

! before you start taking Mycophenolate

mofetil,

! during your entire treatment with

Mycophenolate mofetil,

! for 6 weeks after you stop taking

Mycophenolate mofetil.

Talk to your doctor about the most suitable contraception for you. This will depend on your individual situation. Two forms of contraception are preferable as this will reduce the risk of unintended pregnancy. Contact your doctor as soon as possible, if you think your contraception may not have been effective or if you have forgotten to take your contraceptive pill.

Mycophenolate causes birth defects and miscarriage. If you are a woman who could become pregnant, you must provide a negative pregnancy test before starting treatment and must follow the contraception advice given to you by your doctor.

Your doctor will speak to you and give you written information, particularly on the effects of mycophenolate on unborn babies. Read the information carefully and follow the instructions. If you do not fully understand these instructions, please ask your doctor to explain them again before you take mycophenolate. See also further information in this section under “Warnings and Precautions” and “Pregnancy and breast-feeding”.

Do not take Mycophenolate mofetil:

! if you are allergic (hypersensitive) to

mycophenolate mofetil, mycophenolic acid or any of the other ingredients in this medicine (listed in section 6),

! if you are a woman who could be pregnant and

you have not provided a negative pregnancy test before your first prescription, as mycophenolate causes birth defects and miscarriage,

! if you are pregnant or planning to become

pregnant or think you may be pregnant, ! if you are not using effective contraception

(see Pregnancy, contraception and breast-feeding),

! if you are breast-feeding.

Do not take this medicine if any of the above applies to you. If you are not sure, talk to your doctor or pharmacist before taking Mycophenolate mofetil.

Warnings and precautions

Talk to your doctor straight away before taking Mycophenolate mofetil:

! if you have a sign of infection such as a fever or

sore throat,

! if you have any unexpected bruising or

bleeding,

! if you have ever had a problem with your

digestive system, such as a stomach ulcer, ! if you are planning to become pregnant or if

you get pregnant whilst taking Mycophenolate mofetil.

If any of the above apply to you (or you are not sure), talk to your doctor straight away before taking Mycophenolate mofetil.

You are a woman who is not capable of becoming pregnant if any of the following applies to you: ! you are post-menopausal, i.e. at least 50 years

old and your last period was more than a year ago (if your periods have stopped because you have had treatment for cancer, then there is still a chance you could become pregnant), ! your fallopian tubes and both ovaries have

been removed by surgery (bilateral salpingo-oophorectomy),

! your womb (uterus) has been removed by

surgery (hysterectomy),

! your ovaries no longer work (premature

ovarian failure, which has been confirmed by a specialist gynaecologist),

! you were born with one of the following rare

conditions that make pregnancy impossible; the XY genotype, Turner's syndrome or uterine agenesis,

! you are a child or teenager who has not started

having periods.

Contraception in men taking Mycophenolate mofetil

The available evidence does not indicate an increased risk of malformations or miscarriage if the father takes mycophenolate. However, a risk cannot be completely excluded. As a precaution you or your female partner are recommended to use reliable contraception during treatment and for 90 days after you stop taking Mycophenolate mofetil.

If you are planning to have a child, talk to your doctor about the potential risks.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Your doctor will talk to you about the risks in case of pregnancy and the alternatives you can take to prevent rejection of your transplant organ if:

! you plan to become pregnant,

! you miss or think you have missed a period, or

you have unusual menstrual bleeding, or suspect you are pregnant,

! you have sex without using an effective method

of contraception.

If you do become pregnant during treatment with mycophenolate, you must inform your doctor immediately. However, keep taking Mycophenolate mofetil until you see him or her.

Pregnancy

The effect of sunlight

Mycophenolate mofetil reduces your body's defences. As a result, there is an increased risk of skin cancer. Limit the amount of sunlight and UV light you get. Do this by:

! wearing protective clothing, which also covers

your head, neck, arms and legs,

! using a sunscreen with a high protection

factor.

Other medicines and Mycophenolate mofetil

Mycophenolate causes a very high frequency of miscarriage (50%) and severe birth defects (23% - 27%) in the unborn baby. Birth defects which have been reported include anomalies of ears, of eyes, of face (cleft lip/palate), of development of fingers, of heart, oesophagus (tube that connects the throat with the stomach), kidneys and nervous system (for example spina bifida (where the bones of the spine are not properly developed)). Your baby may be affected by one or more of these.

Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines. This includes medicines obtained without a prescription, including herbal medicines. This is because Mycophenolate mofetil can affect the way some other medicines work. Also, other medicines can affect the way Mycophenolate mofetil works.

If you are a woman who could become pregnant, you must provide a negative pregnancy test before starting treatment and must follow the contraception advice given to you by your doctor. Your doctor may request more than one test to ensure you are not pregnant before starting treatment.

Breast-feeding

In particular, tell your doctor or pharmacist if you are taking any of the following medicines before you start Mycophenolate mofetil:

! azathioprine or other medicines which

suppress your immune system - given after a transplant operation,

! cholestyramine - used to treat high cholesterol, ! rifampicin - an antibiotic used to prevent and

treat infections such as tuberculosis (TB) ! antacids or proton pump inhibitors - used for

acid problems in your stomach such as indigestion,

! phosphate binders - used by people with

chronic kidney failure to reduce how much phosphate is absorbed into their blood,

Do not take Mycophenolate mofetil if you are breast-feeding. This is because small amounts of the medicine can pass into the mother's milk.

Driving and using machines

Mycophenolate mofetil has a moderate influence on your ability to drive or use any tools or machines. If you feel drowsy, numb or confused, talk to your doctor or nurse and do not drive or use any tools or machines until you feel better.

3

How to take Mycophenolate mofetil

Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.

Front

5 mm

5 mm

How much to take

The amount you take depends on the type of transplant you have had. The usual doses are shown below. Treatment will continue for as long as you need to prevent you from rejecting your transplant organ.

Kidney transplant

Adults

! The first dose is given within 3 days of the

transplant operation.

! The daily dose is 8 capsules (2 g of the

medicine) taken as two separate doses. ! Take 4 capsules in the morning and then 4

capsules in the evening.

Children (aged 2 to 18 years)

! The dose given will vary depending on the size

of the child.

! Your doctor will decide the most appropriate

dose based on your child's height and weight (body surface area measured as square metres

2 2 or “m ”). The recommended dose is 600 mg/m taken twice a day.

Heart transplant

Adults

! The first dose is given within 5 days of the

transplant operation.

! The daily dose is 12 caspules (3 g of the

medicine) taken as two separate doses. ! Take 6 capsules in the morning and then 6

capsules in the evening.

Children

! There is no information for the use of

Mycophenolate mofetil in children with a heart transplant.

Liver transplant

Adults

! The first dose of oral Mycophenolate mofetil

will be given to you at least 4 days after the transplant operation and when you are able to swallow oral medicines.

! The daily dose is 12 capsules (3 g of the

medicine) taken as two separate doses. ! Take 6 capsules in the morning and then 6

capsules in the evening.

Children

! There is no information for the use of

Mycophenolate mofetil in children with a liver transplant.

Taking the medicine

Swallow your capsules whole with a glass of water ! Do not break or crush them,

! Do not take any capsules that have broken

open or split.

Take care not to let any powder from inside a broken capsule get into your eyes or mouth. ! If this happens, rinse with plenty of plain water. Take care not to let any powder from inside a broken capsule get onto your skin.

! If this happens, wash the area thoroughly with

soap and water.

If you take more Mycophenolate mofetil than you should

If you take more Mycophenolate mofetil than you should, talk to a doctor or go to a hospital straight away. Also do this if someone else accidentally takes your medicine. Take the medicine pack with you.

If you forget to take Mycophenolate mofetil

If you forget to take your medicine at any time, take it as soon as you remember. Then continue to take it at the usual times. Do not take a double dose to make up for a forgotten dose.

If you stop taking Mycophenolate mofetil

Do not stop taking Mycophenolate mofetil unless your doctor tells you to. If you stop your treatment, you may increase the chance of rejection of your transplant organ.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4

Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Talk to a doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment:

! you have a sign of infection such as a fever or

sore throat,

! you have any unexpected bruising or

bleeding,

! you have a rash, swelling of your face, lips,

tongue or throat, with difficulty breathing - you may be having a serious allergic reaction to the medicine (such as anaphylaxis or angioeodema).

Usual problems

Some of the more usual problems are diarrhoea, fewer white cells or red cells in your blood, infection and vomiting. Your doctor will do regular blood tests to check for any changes in: ! the number of your blood cells,

! the amount in your blood of things like sugar,

fat or cholesterol.

Children may be more likely than adults to have some side effects. These include diarrhoea, infections and fewer white cells and fewer red cells in the blood.

Fighting infections

Mycophenolate mofetil reduces your body's defences. This is to stop you rejecting your transplant. As a result, your body will not be as good as normal at fighting infections. This means you may catch more infections than usual. This includes infections of the brain, skin, mouth, stomach and gut, lungs and urinary system.

Lymph and skin cancer

As can happen in patients taking this type of medicine (immune-suppressants), a very small number of mycophenolate patients have developed cancer of the lymphoid tissues and skin.

General unwanted side effects

You may get general side effects affecting your body as a whole. These include serious allergic reactions (such as anaphylaxis, angioeodema), fever, feeling very tired, difficulty sleeping, pains (such as stomach, chest, joint or muscle, pain on passing urine), headache, flu symptoms and swelling.

148 mm

Other unwanted effects may include:

Skin problems such as:

! acne, cold sores, shingles, skin growth, hair loss, rash and itching

Urinary problems such as:

! kidney problems or the urgent need to pass water (urine), blood in the urine

Digestive system and mouth problems such as: ! swelling of the gums and mouth ulcers, ! inflammation of the pancreas, colon or stomach, ! gut problems including bleeding, liver problems, ! constipation, feeling sick (nausea), indigestion, loss of appetite, flatulence.

Nervous system problems such as:

! feeling dizzy, drowsy or numb,

! tremor, muscle spasms, convulsions (fits), ! feeling anxious or depressed, changes in your mood or thoughts.

Heart and blood vessel problems such as: ! change in blood pressure, unusual heartbeat, widening of blood vessels.

Lung problems such as:

! pneumonia, bronchitis,

! shortness of breath, cough, which can be due to bronchiectasis (a condition in which the lung airways are abnormally dilated) or pulmonary fibrosis (scarring of the lungs). Talk to your doctor if you develop a persistent cough or breathlessness,

! fluid on the lungs or inside the chest, ! sinus problems.

Other problems such as:

! weight loss, gout, high blood sugar, bleeding and bruising.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5

How to store Mycophenolate mofetil

! Keep this medicine out of the sight and reach of children.

! Do not use this medicine after the expiry date which is stated on the carton (EXP) and blister. The expiry date refers to the last day of that month.

! Do not store above 30°C.

! Store in the original package in order to protect from moisture.

! Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.

6

Contents of the pack and other information

What Mycophenolate mofetil contains

! The active substance is mycophenolate mofetil. Each capsule contains 250 mg mycophenolate mofetil.

! The other ingredients are:

Capsule content

Pregelatinised starch

Croscarmellose sodium

Povidone (K 90)

Magnesium stearate

Capsule shell

Gelatin

Indigo carmine (E132)

Titanium dioxide (E171)

Iron oxide red (E172)

Iron oxide yellow (E172)

Printing ink

Shellac

Black iron oxide (E172)

Potassium hydroxide

What Mycophenolate mofetil looks like and contents of the pack

Mycophenolate mofetil are Size '1 ', two-piece, hard gelatin capsules, with a blue opaque cap and a brown opaque body, with "EM" printed in black on the capsule cap and “250” printed in black on the capsule body, filled with white to off-white granular powder.

Mycophenolate mofetil 250mg capsules are supplied in 100 x 1 and 300 x 1 capsules in PVC white opaque/aluminium foil perforated unit dose blisters.

Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer

Tillomed Laboratories Limited

220 Butterfield, Great Marlings

Luton, LU2 8DL

United Kingdom

This medicinal product is authorised in the Member States of the EEA under the following names:

United Kingdom Mycophenolate mofetil

250 mg capsules

Germany Mycophenolat mofetil

Tillomed 250 mg kapseln Italy Micofenolato Mofetile Tillomed

Italia

Croatia Mofetilmikofenolat Tillomed

250 mg capsule

Spain Micofenolato de mofetilo

Tillomed 250 mg cápsulas EFG France MYCOPHÉNOLATE MOFÉTIL

TILLOMED 250 mg, gélule

This leaflet was last revised in 08/2020

145

Back

5 mm

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk)

Last revision stated in the text: August 2020

What the sections and the side effect frequencies mean: How to read a patient leaflet

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Mycophenolate Mofetil Tillomed 250 mg capsules

What these facts mean

Prescription needed?? Yes, prescription-only medicine (POM)
Active substance? Mycophenolate mofetil
Strength? 250 mg
Pharmaceutical form? Oral capsule
Size '1', two-piece, hard gelatin capsules, with a blue opaque cap and a brown opaque body with "EM" printed in black on the capsule cap and "250" printed in black on the capsule body, filled with white to off-white granular powder.
How is it taken? Oral
Excipients? Pregelatinised starch, Croscarmellose sodium, Povidone (K 90), Magnesium stearate, Gelatin, Indigo carmine (E132), Titanium dioxide (E171), Iron oxide red (E172), Iron oxide yellow (E172), Shellac, Black iron oxide (E172), Potassium hydroxide
Pack sizes 100 capsule
Is it available?? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life? 3 years
Storage Do not store above 30°C. Store in the original package in order to protect from moisture.
Drug group (ATC)? Immunosuppressive agents
  1. L Antineoplastic and immunomodulating agents
    1. L04 Immunosuppressants
      1. L04A Immunosuppressants
        1. L04AA Selective immunosuppressants
          1. L04AA06 mycophenolic acid
Marketing authorisation? PL 11311/0591 (first authorised 1 October 2025)
Marketing authorisation holder? Tillomed Laboratories Limited
Codes? GTIN 5024655004935 · BNF 08020100

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 11.1.0 of 9 November 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.